-
-
Call more information
660-596-2224 -
A panel of government health advisers said Friday there’s no clear evidence that a harder-to-crush version of the painkiller OxyContin designed to discourage abuse actually resulted in fewer overdoses or deaths. The conclusion from the Food and Drug Administration advisory panel comes more than a decade after Purdue Pharma revamped its blockbuster opioid, which has […]
Read MoreBy Amy Orciari Herman NEJM Journal Watch Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Three quarters of SARS-CoV-2-related deaths in U.S. youth under age 21 occurred among those with underlying health conditions, an MMWR study finds. CDC researchers identified 121 deaths related to COVID-19 or multisystem inflammatory syndrome in children (MISC) in […]
Read MoreBY Nancy Crotti Centers for Disease Control and Prevention Summary What is already known about this topic? Delayed or avoided medical care might increase morbidity and mortality associated with both chronic and acute health conditions. What is added by this report? By June 30, 2020, because of concerns about COVID-19, an estimated 41% of U.S. adults […]
Read MoreASA In formal comments responding to the Centers for Medicare & Medicaid Services (CMS) proposed rule for the CY2021 Medicare Physician Fee, ASA is urging CMS to work with Congressional leaders to pass legislation to prevent the implementation of scheduled Medicare payment cuts on January 1, 2021. ASA’s comments describe grave concerns about the proposed cuts to […]
Read MoreBy Pat Anson, PNN Editor Pain News Network We’ve learned some weird things about acetaminophen in recent years. The pain reliever not only helps treat headaches and fevers; it also appears to dull human emotions and have other psychological effects. A new study at The Ohio State University suggests that acetaminophen could even make you […]
Read MoreThis is for our readers who treat pain patinets. Author: Veronica McGuire MCMASTER UNIVERSITY Other forms of treatments are as effective as opioids and have less risk of harms to patients Two new evidence reviews related to acute musculoskeletal injuries like strains and sprains suggest other forms of treatments are as effective as opioids and […]
Read MoreBy Amy Orciari Herman NEJM Journal Watch Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS Over 14% of U.S. high school students report misusing prescription opioids at least once, according to findings from the 2019 Youth Risk Behavior Survey published in MMWR. Among the other findings, based on data collected from nearly 14,000 high […]
Read MoreBy Kelly Young NEJM Journal Watch Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Asthma doesn’t seem to be a major risk factor for COVID-19 hospitalization or intubation, suggests a study in the Annals of the American Thoracic Society. Researchers analyzed 15 studies of patients hospitalized for COVID-19. They found that the prevalence of […]
Read MoreBy Kelly Young NEJM Journal Watch Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Combined palatal and tongue surgery may help patients with obstructive sleep apnea that hasn’t responded to other treatments, suggests a preliminary trial in JAMA. Roughly 100 adults in Australia with moderate-to-severe obstructive sleep apnea (apnea-hypopnea index of 15 or more […]
Read MoreAutors: Tomoki Sasakawa, MD, PhD; Katsuyuki Miyasaka, MD, PhD; Tomohiro Sawa, MD, PhD; Hiroki Iida, MD, PhD Anesthesia Safety Patient Foundation Vol 35 No 2 June 2020 Introduction Sugammadex rapidly reverses neuromuscular blockade via selective encapsulation of rocuronium and other nondepolarizing aminosteroid muscle relaxants. Since its 2010 launch in Japan, sugammadex has been administered to […]
Read More